Celecoxib substituted biotinylated poly (amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent
Authors: Łukasz Uram, Joanna Markowicz, Maria Misiorek, Aleksandra Filipowicz-Rachwał, Stanisław Wołowiec, Elżbieta Wałajtys-Rode
Published in: European Journal of Pharmaceutical Sciences
Publication type: article
Subject areas: Pharmacology, Toxicology and Pharmaceutics
SJR best quartile: Q1